SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Secret_Agent_Man who wrote (813)5/6/1998 7:52:00 PM
From: seminole  Read Replies (1) of 2135
 
Byron

Their is too much talk of shrinking tumors in mice and
not enough talk about the variety and aggressiveness
of the tumors used in the mouse model in this testing.
In short, has the drug been tested on aggressive human
tumors capable of metastases and multidrug resistance
or something that makes their data look good. This is not
an attack on your drug or stock but a warning to be
careful out there. As an investors you need to focus on the
tumor type not the number of tumors that shrink.

Wishing I had a dollar for every mouse tumor my drug shrank
richard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News